... the conventional economic model, and then provides a number of health applications. It concludes that by not considering the validity of these assumptions in health care applications, researchers and policy analysts will blind themselves to policy options that may be most effective in improving social...

... attention to this possibility. “You shall not put a stumbling block before the blind.” Leviticus 19:14. “Publicity is … a remedy for social and industrial diseases. Sunlight is said to be the best disinfectant.” Louis Brandeis, Other People's Money . Copyright © 1981 by the Dept. of Health Administration...

...Gunnar Dybwad Diane Driedger, The Last Civil Rights Movement: Disabled Peoples' International (New York: St. Martin's, 1989), 137 pp., $35.00 cloth, $15.95 paper. Copyright © 1990 by Duke University Press 1990 References National Federation of the Blind. 1970 . The First Thirty...

...Lisa I. Iezzoni James I. Charlton. Nothing about Us without Us: Disability Oppression and Empowerment . Berkeley: University of California Press,1998. 194 pp. $27.50 cloth; $16.95 paper; Rod Michalko. The Two in One:Walking with Smokie, Walking with Blindness . Philadelphia: Temple...

... Federation of the Blind. 1970. The First Thirty Years: A History ofthe National Federation of the Blind. Des Moines, IA: NFB. Tigar, M. 1989. Reflections on the Life and Work of Jacobus TenBroek. Braille Monitor, March, pp. 76-179. Books in Brief Lu Ann Aday, Designing and Conducting...

... treatment group and a control group of subjects (patients) with similar characteristics, thereby reducing the probability that nontherapeutic factors, known as confound- ers, may influence the outcome. Confounders are factors such as age, socioeconomic status, and comorbidities. RCTs also blind or...

... similar characteristics, thereby reducing the probability that nontherapeutic factors, known as confound- ers, may influence the outcome. Confounders are factors such as age, socioeconomic status, and comorbidities. RCTs also blind or mask both researchers and subjects so that neither knows who is...

... comorbidities. RCTs also blind or mask both researchers and subjects so that neither knows who is in the treatment or control group. Such knowledge is known to affect experimental outcomes. Lower on the EBM pyramid are several types of observational studies, which examine the results of tests and...

... unalloyed success, survey data suggest a high level of satis- faction with the system among Medicaid recipients. This success seems even more extraordinary given the fact that Oregon has integrated its aged, blind, disabled, and mentally ill populations into its Medicaid man- aged care, a population...

... California Press, 1998. 255 pp. $35.00 cloth. The Two in One: Walking with Smokie, Walking with Blindness. Rod Michalko. Philadelphia: Temple University Press, 1999. 256 pp. $44.95 cloth; $16.95 paper. Law and Ethics Abortion Law and Politics Today. Ellie Lee, ed. New York: St. Martin’s, 1998. 251 pp...

... the quality of the research which must be done in order to validate that safety and effective- ness. Will double-blind studies be required and how will consent be obtained? Are terminal patients likely to risk getting into the placebo cohort-especially for a drug aimed at palliation when...

... symposium with contributions. 108 pp. New York: American Foundation for the Blind, and Washington, DC: President’s Committee for Employment of the Hand- icapped, 1986. $10.00 Medical Innovation and Bad Outcomes: Legal, Social, and Ethical Responses. Edited by Mark Siegler. 304 pp. Ann Arbor...

... to essentially all comers from their communities, including vaccinations and services for the blind, the deaf, the disabled, the aged, and the mentally ill. Haeder found strong evidence that various coverage expansions by state and federal governments, such as Medicaid and Medicare—intended to make...

... advancing age. Statistics from the National Institutes of Health, published in 1973, indicate that the prevalence of legal blindness (distance vision of 20/200 or worse with best correction using ordinary lenses or a visual field limited to 20 degrees or less at the widest point) ranges from...

... Development . 2004 . Towards High-Performing Health Systems . Summary Report . Paris : OECD . Oxfam International . 2009 . Blind Optimism: Challenging the Myth about Private Health Care in Poor Countries . Oxfam Briefing Paper . February 12 . London : Oxfam International . Oxfam, VSO...

... lunatics next to the deaf and the physically deformed next to the blind. Even in its discussion of highly technical issues, the book grips the reader. One must strain to find fault with the volume. While readers may disagree with some of Stone’s interpretations, they are all plausible and well...

... wishes he had staked out a smaller ter- ritory and cultivated it more thoroughly. For example, Albrecht illustrates the dynamism and profitability of the rehabilitation industry by citing New York’s $8 billion expenditure on Medicaid services to aged, blind, and disabled recipients (p. 135...

...; Gail Berkowitz, Institute of Health Policy Studies, University of California, San Francisco; Monroe Lerner. Johns Hopkins University (replacing Dorothy Jessop. who resigned); and Comne Kirchner, American Foundation for the Blind. The members were reelected: Eugene Litwak. Columbia...

... blind the analyst to the open-endedness that exists at the critical points in the unfolding of those events. Both pre- and postwar developments of the PHS research enterprise deserve a more robust treatment. Institute of Medicine Richard A. Rettig Claudia Huerkamp...

... historical analysis. One concludes, contrary to this book, that the pre-World War I1 NIH and post- war NIH were vastly different enterprises. A retrospective view of events will always reveal elements of continuity, but that should not blind the analyst to the open-endedness that exists at the...